Case Study:
Finding Ultra Rare Disease Patients with AI Using Claims and EHR Data
Ultra Rare Disease Patient Identification Using AI with Claims and EHR Data
Ultra rare disease patients are notoriously difficult to find due to the fact that they are ultra rare.
The Client Problem
Finding patients with a specific ultra rare disease was difficult for the client. They did all the usual approaches of educating every physician who may come into contact with a patient of this type but this was costing significantly and yielding little return.
The Solution
The team turned to Eularis for Artificial Intelligence Powered Analytics to help. We were given access to claims databases that the client had purchased. We began by identifying the patient journey of the few patients who had been diagnosed, and from that, we were able to understand the specifics of the tests and medical journey of those patients. We then also accessed EHR data that we have the ability to source from over 30 countries and used that to then identify other patients with similar early-stage symptoms with a high probability of having the condition.
The Outcome
29 previously undiagnosed patients were able to get confirmed diagnoses and appropriate treatment early in their disease progression which led to an improved clinical outcome for them and a significant financial return for the client. Considered the ultra-rare condition, this was an extremely high number of additional patients resulting in hundreds of millions of additional revenue for the lifetime of these patients.
To achieve these kinds of results, contact Eularis today.
Latest Blogs
Check out our latest blogs
How to Overcome AI Resistance and Build an AI-Ready Workforce
In 2026, 81% of physicians reported using AI for work, more than double the 38% the American Medical Association recorded in 2023. Yet AI adoption
Nobody Has Banned AI in HTA Submissions. Everybody Has Made You Answerable for It.
What NICE, CDA-AMC and the new EU JCA principles now expect the moment AI touches your evidence, and the questions nobody has answered yet On
The Vendor You Evaluated Last Year Is Not the Product You Have Now Licensed
Somewhere in your organisation, there is a slide deck from twelve months ago. It has a scorecard on it. Green, amber, a few reds that